LRP1B and gastric cancer: More recently, evaluation of LRP1B expression in gastric cancer patient samples showed that cytoplasmic LRP1B was significantly associated with a low clinicopathological stage and favorable prognosis of patients with diffuse-type gastric cancer, but not with intestinal-type gastric cancer [109].